IRIS - Res&Arch Institutional Research Information System - Research & Archive

LIBERATI, Anna Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.313
EU - Europa 9.421
AS - Asia 8.215
SA - Sud America 2.066
Continente sconosciuto - Info sul continente non disponibili 1.323
AF - Africa 243
OC - Oceania 36
Totale 35.617
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.700
SG - Singapore 3.833
IE - Irlanda 1.700
BR - Brasile 1.617
RU - Federazione Russa 1.514
UA - Ucraina 1.404
IT - Italia 1.349
VN - Vietnam 1.129
SE - Svezia 1.033
HK - Hong Kong 986
CN - Cina 962
DE - Germania 588
FR - Francia 561
FI - Finlandia 544
GB - Regno Unito 275
CA - Canada 243
IN - India 203
BD - Bangladesh 198
AR - Argentina 132
KR - Corea 132
TR - Turchia 119
IQ - Iraq 101
MX - Messico 101
AT - Austria 95
PK - Pakistan 72
CO - Colombia 71
EC - Ecuador 70
UZ - Uzbekistan 70
CH - Svizzera 67
ZA - Sudafrica 66
ID - Indonesia 62
PL - Polonia 55
NL - Olanda 53
VE - Venezuela 47
CL - Cile 46
PH - Filippine 44
SA - Arabia Saudita 43
MA - Marocco 42
CR - Costa Rica 41
JP - Giappone 39
SV - El Salvador 38
ES - Italia 37
CW - ???statistics.table.value.countryCode.CW??? 34
AU - Australia 33
HN - Honduras 32
GT - Guatemala 30
PY - Paraguay 29
NI - Nicaragua 28
TN - Tunisia 28
LB - Libano 27
PE - Perù 27
RO - Romania 27
IL - Israele 24
MY - Malesia 24
PR - Porto Rico 24
JM - Giamaica 22
KE - Kenya 22
TT - Trinidad e Tobago 21
GR - Grecia 19
CZ - Repubblica Ceca 18
EU - Europa 18
BE - Belgio 17
BO - Bolivia 17
AE - Emirati Arabi Uniti 16
EG - Egitto 15
NP - Nepal 15
ET - Etiopia 14
JO - Giordania 14
DZ - Algeria 11
KZ - Kazakistan 11
TH - Thailandia 11
GP - Guadalupe 9
PS - Palestinian Territory 9
AZ - Azerbaigian 8
OM - Oman 8
SC - Seychelles 8
UY - Uruguay 8
AL - Albania 7
EE - Estonia 7
MD - Moldavia 7
PA - Panama 7
TW - Taiwan 7
BB - Barbados 6
DO - Repubblica Dominicana 6
RS - Serbia 6
SN - Senegal 6
SY - Repubblica araba siriana 6
BG - Bulgaria 5
KG - Kirghizistan 5
KW - Kuwait 5
LT - Lituania 5
PT - Portogallo 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
GE - Georgia 4
BH - Bahrain 3
CI - Costa d'Avorio 3
Totale 34.283
Salva come PNG Salva come JPEG
Città #
Singapore 2.502
Dublin 1.697
Chandler 1.371
Ashburn 1.202
San Jose 1.168
San Mateo 1.079
Hong Kong 975
Dong Ket 667
Boardman 628
Santa Clara 596
Council Bluffs 543
Moscow 528
Altamura 491
Medford 480
Princeton 479
Wilmington 408
Lauterbourg 406
Lawrence 372
Andover 351
Jacksonville 321
Perugia 254
Ann Arbor 210
Ho Chi Minh City 166
Beijing 157
Des Moines 145
The Dalles 143
São Paulo 137
Saint Petersburg 136
Seoul 124
Los Angeles 122
New York 104
Norwalk 95
Hanoi 92
Falls Church 69
Helsinki 66
San Paolo di Civitate 64
Houston 62
Munich 61
North Bergen 57
Piscataway 54
Shanghai 51
Izmir 50
Woodbridge 49
Rio de Janeiro 48
Rome 46
Toronto 44
Dallas 43
Vienna 43
Montreal 42
Belo Horizonte 41
Phoenix 41
Nuremberg 38
Baghdad 36
Orem 36
Frankfurt am Main 35
Chicago 34
Brasília 33
San Salvador 33
Tokyo 33
Brooklyn 32
San José 32
Willemstad 32
Dhaka 30
Milan 30
Chennai 29
Atlanta 28
Denver 28
Guangzhou 28
Tashkent 28
Warsaw 28
Porto Alegre 27
London 26
Managua 26
Guatemala City 25
Guayaquil 25
Johannesburg 25
Curitiba 24
Haiphong 24
Santiago 23
San Francisco 22
Turku 22
Campinas 21
Mumbai 21
Quito 21
Dearborn 20
Istanbul 20
Jeddah 20
Medellín 20
Redwood City 20
Lahore 19
Mexico City 19
Secaucus 19
Cape Town 18
Caracas 18
Den Haag 18
Lima 18
Philadelphia 18
Salvador 18
Boston 17
Brussels 17
Totale 20.314
Salva come PNG Salva come JPEG
Nome #
Integration of Traditional and Western Medicine in Vietnamese Populations: A Review of Health Perceptions and Therapies 182
Anti-rheumatoid arthritis activity of decoction from the leaves of the tree Artocarpus tonkinensis used in Vietnamese traditional medicine 177
WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (WKCYD) FOLLOWED BY MAINTENANCE WITH WEEKLY CARFILZOMIB (WK) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) 172
Artocarpus tonkinensis protects mice against collagen-induced arthritis and decreases Th17 cell function 172
Anti-cancer activity of compounds isolated from Bursera microphylla 169
[Metastatic gastric cancer successfully treated with surgery and chemotherapy. Case report]. 165
Occurrence of the same chromosome abnormalities in Ph+ and Ph- cells in chronic myeloid leukaemia. Evidence of a secondary origin of the Ph chromosome? 164
67Ga scan detects residual active disease and it is predictive of disease-free survival in malignant lymphoma patients 160
Anti-cancer activity of compounds isolated from Bursera microphylla. 157
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial. 153
Maesopsin 4-O-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN! and BCAS3 in acute myeloid leukemia 152
Monitoring treatment and survival in chronic myeloid leukemia. 148
67Ga scan detects residual active disease and it is predictive of disease-free survival in malignant lymphoma patients. 144
67Ga-scan detects residual active disease and it is predictive of disease-free survival in classical Hodgkin's disease patients 144
67Ga-SPECT/CT with a hybrid system in the clinical management of lymphoma 144
A 4-day chemosensitivity assay in vitro reliably predicts clinical response of patients with acute leukemia 136
Role of microRNAs in the activity of new therapeutic inhibitors of Src kinases in CD133+ colorectal cancer cells 132
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned 131
Prognosi e terapia del mieloma multiplo. 131
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma. 131
R-CHOP vs R-miniCEOP for the initial treatment of elderly “fit“ patients with diffuse large B-cell lymphoma. Results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi (IIL) 130
A case of acute myeloid leukemia with deletion of chromosome 7 following PBSC transplantation. 128
Addition of rituximabto dose-denseand high dose chemotherapy with autologous transplantation in untreated poor-prognosis diffuse large B-cell lymphoma: Results of phase II trial 126
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi. 126
SUMO proteins: Guardians of immune system 124
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up. 123
67Ga-scan usefulness in predicting the clinical outcome and the long-term effects of chemotherapy in lymphoma patients 123
Could thymomectomy be a reasonable option for non-myasthenic thymoma patients? 122
All-trans-retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase. 121
Bcl-xL overexpression decreases GILZ levels and inhibits glucocorticoid-induced activation of caspase-8 and caspase-3 in mouse thymocytes 120
Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma. 119
Pharmacological modulation of caspase-8 in thymus-related medical conditions. 119
A continous recurrent course in a case of nodular-sclerosis (NS) classical Hodgkin's lymphoma (cHL) associated with Castleman's disease (CD) 118
Evaluation of response to therapy with 67Ga scintigraphy, CT scan and magnetic resonance in malignant lymphomas. 118
The therapeutic effect of new Src inhibitor in colon cancer cells and potential role of mir494. 117
Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients. 116
Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. 114
Lenalidomide and its role in the management of multiple myeloma. 114
GM-CSF: clinical trials in non-Hodgkin's lymphoma patients with chemotherapy induced leucopenia. 112
Rare immunological presentation in B-cell chronic lymphocytic leukaemia. 112
Antibodies binding granulocyte-macrophage colony stimulating factor produced by cord blood-derived B cell lines immortalized by Epstein-Barr virus in vitro. 111
Cell membrane markers and phytohemagglutinin reactivity of circulating lymphocytes from chronic myelocytic leukemia patients. 111
Effectiveness and Safety of Combined Cytoreductive Therapy In 56 Patients With Essential Thrombocythaemia: Report of the Registro Italiano Trombocitemie (rit) 111
The Hexane Fraction of Bursera microphylla A Gray Induces p21-Mediated Antiproliferative and Proapoptotic Effects in Human Cancer-Derived Cell Lines 111
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients 109
La scintigrafia ossea nella diagnosi e nel "follow-up" del carcinoma mammario. 109
Fattori prognostici nel carcinoma colon-retto. 109
Fusarubin and anhydrofusarubin isolated from a Cladosporium species inhibit cell growth in human cancer cell lines 109
L'interferone alfa nella leucemia mieloide cronica 107
5-Fluorouracil, vincristine and hydroxyurea combination chemotherapy in metastatic colorectal cancer. 107
Complex translocations of the Ph chromosome and Ph-negative CML arise from similar mechanisms as evidenced by FISH analysis. 107
Anagrelide in essential thrombocythemia: a retrospective analysis of 220 patients 106
In vitro synergistic activity of PDN-IFN alpha and NM + IFN alpha combinations on fresh bone-marrow samples from multiple myeloma patients. 105
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma 105
Osimertinib 105
Imatinib and pegylated human recombinat interferon-alpha2b in early chronic phase chronic myeloid leukaemia. 105
Myelomonocytic-associated antigens in a case of genotypically, phenotypically and functionally B-cell lymphoma. 104
Phase I-II trial on natural beta interferon in chemoresistant and relapsing multiple myeloma. 104
Isolation and identification of bioactive molecules from resins used in traditional medicine: Commiphora erythraea and Bursera microphylla 104
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial. 102
Rapid and sustained response of an intra- and extracranial large cell lymphoma mass to liposomal intrathecal Ara-C and R-MegaCEOP systemic chemotherapy. 102
A brief course of chemo-immunotherapy FND plus rituximab is effective to induce a high clinical and molecular response in elderly patients with advanced stage follicular lymphoma (FL) at diagnosis. 102
Long term outcome of Ph plus CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era. 102
The role of autotransplantation in chronic lymphocytic leukemia and results from the italian group. 101
Pharmacologic and immunologic effects of human leukocyte interferons in patients with neoplasia: an interim report. 101
Indicazione all’autotrapianto in prima linea nel linfoma non-Hodgkin’s aggressivo. 100
Melphalan 200 mg/m2 versus Melphalan 100 mg/m2 in newly diagnosed myeloma patients: a prospective, multi-center phase III study. 99
Interferon Alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia. A study of 82 patients treated with intermittent administration. 99
Ph '-positive (Ph '+) chronic myeloid leukemia (CML) presenting as Ph ' plus T-lymphoblastic lymphoma (LL) resistant to high-dose chemotherapy and Gleevec. 98
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma 98
Efficacy and safety of yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem cell transplantation. 97
Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer. 97
Pre-autologous stem cell transplantation (ASCT) treatment with rituximab does not impair stem cell harvest and engraftment in untreated patients with diffuse large B-cell lymphoma (B-DLCL) at poor prognosis 96
Conventional induction treatments do not influence overall survival in multiple myeloma. 96
Evaluation of response therapy with 67Ga scintigraphy, CT scan and magnetic resonance in malignant lymphomas. 96
Interferon-alpha-2b as therapy for untreated and pretreated patients with Ph' positive chronic myeloid leukemia 96
A phase I study of human natural interferon-beta in cancer patients. 96
Hydroxyurea Treatment In 1075 Patients with Essential Thrombocythemia and Occurrence of Extra-Hematological Adverse Events: A Preliminary Report of the Registro Italiano Trombocitemia (RIT) 96
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled-trial 95
Chronic myeloid leukemia, BCR/ABL transcript, response to alpha-interferon and survival. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. 95
Staging of chronic myeloid leukaemia. 94
Immunologic profile in patients with Hodgkin's disease in complete remission. 93
Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice. 93
A continous recurrent course in a case of nodular-sclerosis (NS) classical Hodgkin's lymphoma (cHL) associated with Castleman's disease (CD) 93
A Phase III Study of Enoxaparin vs Aspirin vs Low-Dose Warfarin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Thalidomide Based-Regimens. 93
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 93
Combination chemotherapy with 5-fluorouracil and methyl-CCNU for the treatment of advanced gastrointestinal cancer. 93
Citotossicità spontanea in pazienti con B-LLC. 92
R-CHOP vs R-MiniCEOP in elderly patients with diffuse large B-cell lymphoma (B-DLCL) prospectively selected by a multidimensional evaluation scale: Preliminary results of a Randomized study performed by Intergruppo Italiano Linfomi (IIL) 92
Role of caspase-8 in thymus function 92
Usefulness of 67Gallium scan in evaluating long-term effects of chemotherapy. 91
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage. 89
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma. 89
Complete response correlates with long-term progression-free and overall survivals in elderly myeloma treated with novel agents: analysis of 1175 patients 89
Treatment of Ph-positive Chronic Myeloid Leukemia with alpha-Interferon (Roferon-A). The Italian Cooperative Study Group experience. 89
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi 89
Has 67Ga-scan a role in the evaluation of lymphoma response to conventional or high dose chemotherapy? 88
Has the 67Ga-SPET a role in monitoring Hodgkin and primary mediastinal lymphoma in the PET-FDG age? 88
Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution 88
Trattamento polichemioterapico sequenziale del carcinoma broncogeno inoperabile. 88
Totale 11.385
Salva come PNG Salva come JPEG
Categoria #
all - tutte 178.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.000
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.836 0 0 0 123 125 55 63 1.377 39 67 385 602
2022/20235.594 512 1.044 31 395 402 609 7 253 2.147 6 151 37
2023/20241.834 137 213 107 32 20 15 555 26 80 67 244 338
2024/20254.349 47 548 89 125 569 119 102 384 1.167 357 492 350
2025/20269.911 631 670 795 1.427 890 800 1.691 639 1.210 842 218 98
2026/20273.507 194 245 573 2.495 0 0 0 0 0 0 0 0
Totale 35.617